Similar articles

• Relationship of breast magnetic resonance imaging to outcome after breast-conservation treatment with radiation for women with early-stage invasive breast carcinoma or ductal carcinoma in situ.

  Solin LJ, Orel SG, Hwang WT, Harris EE, Schnall MD. Solin LJ, et al. J Clin Oncol. 2008 Jan 20;26(3):386-91. doi: 10.1200/JCO.2006.09.5448. J Clin Oncol. 2008. PMID: 18202414
• Magnetic resonance imaging identifies multifocal and multicentric disease in breast cancer patients who are eligible for partial breast irradiation.

  Al-Hallaq HA, Mell LK, Bradley JA, Chen LF, Ali AN, Weichselbaum RR, Newstead GM, Chmura SJ. Al-Hallaq HA, et al. Cancer. 2008 Nov 1;113(9):2408-14. doi: 10.1002/cncr.23872. Cancer. 2008. PMID: 18823018
• Magnetic resonance imaging of the breast.

  el Yousef SJ, O'Connell DM. el Yousef SJ, et al. Magn Reson Annu. 1986:177-95. Magn Reson Annu. 1986. PMID: 2856325 No abstract available.
• Current controversies in the treatment of ductal carcinoma in situ of the breast.

  Franceschini G, Terribile D, Magno S, Fabbri C, D'Alba P, Chiesa F, Di Leone A, Scafetta I, Masetti R. Franceschini G, et al. Ann Ital Chir. 2008 May-Jun;79(3):151-5. Ann Ital Chir. 2008. PMID: 18958961 Review.
• [Ductal carcinoma in situ: role of the boost].

  Azria D, Auvray H, Barillot I, Baumann P, Benyoucef A, Bons-Rosset F, Bontemps P, Bourgier C, Breton-Callu C, Cowen D, Cretin J, Delalande B, Denis F, Ellis S, Gaci Z, Hannoun-Lévy JM, Hasbini A, Hennequin C, Lagrange JL, Lartigau E, Latorzeff I, Le Blanc-Onfroy M, Lecouillard I, Lemanski C, Levy C, Maingon P, Marchal C, Monnier A, Pradier O, Racadot S, Romestaing P, Serin D, Simon JM, Teyssier E, Tallet A, Tolédano A, Belkacémi Y. Azria D, et al. Cancer Radiother. 2008 Nov;12(6-7):571-6. doi: 10.1016/j.canrad.2008.07.005. Epub 2008 Aug 13. Cancer Radiother. 2008. PMID: 18703372 Review. French.